Patrys (ASX: PAB) - Favourable data continues to accrue

New note out today on from NDF Research on Patrys, ASX Code PAB, which updates our 19 December 2017 note headlined ‘Cell-penetrating monoclonal antibodies’. You can check it out by clicking here - note the usual disclaimers apply. Below is a video where I discuss what you'll learn in my Patrys update.